What are the driving factors contributing to the growth of the neurovascular devices market?

Factors such as the increasing incidence of neurological diseases, advancements in technology, and the growing interest in minimally invasive procedures are driving the growth of the neurovascular devices market.

What is an example of recent advancements in neurovascular devices?

MicroVention, Inc., a subsidiary of Terumo Corporation, has completed initial enrollment into a multi-center study called STRAIT, evaluating the safety and performance of the BOBBY balloon guide catheter for the treatment of acute ischemic stroke.

How does the lack of skilled healthcare professionals impact the neurovascular devices market?

The skill and experience of healthcare professionals performing neurovascular procedures are critical to their success. The shortage of skilled neurologists and surgeons in some areas can limit the adoption of these procedures.

Are there risks associated with neurovascular procedures?

Neurovascular procedures carry risks such as stroke, bleeding, and infection, which may make patients reluctant to undergo these procedures, potentially impacting the demand for neurovascular devices.

Which technology segment dominates the neurovascular devices market?

Embolization devices and aneurysm-coiling devices are the dominant technology segments in the neurovascular devices market.

What are the primary disease pathologies addressed by neurovascular devices?

Neurovascular devices cater to disease pathologies such as ischemic strokes, cerebral aneurysms, carotid artery stenosis, arteriovenous malformations, and fistulas.

What growth opportunities exist in the neurovascular devices market?

The rise in demand for minimally invasive neurosurgical procedures presents growth opportunities in the neurovascular devices market, along with an aging population and increasing preference for easy diagnosis and simpler procedures.

What are the primary applications of neurovascular devices?

Neurovascular devices are primarily used in applications such as stroke treatment, cerebral artery interventions, cerebral aneurysm repair, and other specific applications.

What is the size of the Neurovascular Devices market in 2023?

The Neurovascular Devices market size is USD 3 billion in 2023.

What is the projected CAGR at which the Neurovascular Devices market is expected to grow at?

The Neurovascular Devices market is expected to grow at a CAGR of 7.6% (2024-2033).

Global Neurovascular Devices Market By Technology (Aneurysm Coiling & embolization Devices, Cerebral Balloon Angioplasty & Stenting Systems, Support Devices, Neurothrombectomy Devices, and Other Technologies), By Disease Pathology (Ischemic Strokes, Cerebral Aneurysm, Carotid Artery Stenosis, Arteriovenous Malformations and Fistuals and Other Diseases), By Size (0.027″, 0.021″, 0.071″, 0.017″, 0.019″, 0.013″, 0.058″, 0.068″ And Other Size), By Application (Stroke, Cerebral Artery, Cerebral Aneurysm, and Other Applications), By End Users (Hospitals & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes, and Other End Users), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Jan 2024
Report ID: 21060
Number of Pages: 310
Format:

- Medtronic plc
- Johnson and Johnson Services Inc.
- Penumbra, Inc
- Microport Scientific Corporation,
- Stryker
- Microvention Inc.
- Codman Neuro
- Abbott
- Terumo Corporation
- Medilit Co. Ltd.
- Evasc
- Rapid Medical